Slide background

ABEC, UNIQUELY ABLE TO SUPPORT THE FIGHT AGAINST COVID-19

For over 45 years, ABEC has exclusively focused on providing customized process solutions and services for the development and manufacturing of the entire range of biopharmaceutical products, including vaccines, antibodies, recombinant proteins, and gene therapy. Privately held and entrepreneurial since inception, our responsiveness and flexibility are essential to our customers’ success, and therefore inherently built into our DNA. With our complete in-house capabilities and industry-leading capacity, no other provider in the industry can match ABEC’s speed in delivering process solutions for COVID-19 biotherapeutics.

ADVANCING COVID-19 VACCINES AND THERAPEUTIC ANTIBODIES

ABEC is supporting multiple industry leaders in their efforts to advance COVID-19 vaccines and therapeutic antibodies. These companies are utilizing ABEC’s full range of customized capabilities, including site services, single-use systems, and stainless-steel equipment. ABEC can:

Customized single-use, stainless steel and hybrid bioprocess solutions. Only ABEC.

The COVID-19 crisis is unique, but ABEC as a company is inherently designed to respond to it.  Our long-term commitment to the industry in the form of innovation and investment is well documented.  Whether reconfiguring existing capacity for COVID-19 therapeutics or building new, email us at info@abec.com or visit our contact page.

A message from ABEC – COVID-19 Update

ABEC is closely monitoring the ongoing Coronavirus Disease 2019 (COVID-19) pandemic.

VISIT ABEC AT AN UPCOMING EVENT

View our global event schedule to learn more.

PRESS RELEASES

CASE STUDIES

Customized single-use, stainless-steel and hybrid bioprocess solutions. ONLY ABEC.

Schedule Today Large-Scale Vessel Electropolishing